What does CUSIP 74365A309 represent in this 13F holders report?

CUSIP 74365A309 is the security identifier for PLX - Protalix BioTherapeutics, Inc. - Common Stock used to aggregate holder disclosures.

How many institutions held PLX - Protalix BioTherapeutics, Inc. - Common Stock in Q3 2022?

26 institutional investors reported PLX - Protalix BioTherapeutics, Inc. - Common Stock for Q3 2022. Use the holders table for investor-level position and value details.

Protalix BioTherapeutics, Inc. - Common Stock (PLX)

CUSIP: 74365A309

Q3 2022 13F Holders as of 30 Sep 2022

Security type / class: Equity / Common Stock
Total 13F shares: 3,548,189
Total 13F value: $3,696,081
Share change: +2,313,590
Put/Call ratio: 28%
SEC-reported price per share: $1.04
Number of holders: 26
Value change: +$2,398,630
Number of buys: 6
Number of sells: 12
Shares outstanding: 80,610,558

Security key

74365A309

Report period

Q3 2022

Institutions

Top holders

PLX full security history Ownership snapshot Full 13F holder table Protalix BioTherapeutics, Inc. SEC filings Protalix BioTherapeutics, Inc. company facts

Broader feeds

Latest 13F filings Latest 13D/G filings Investors directory

Ownership snapshot

Top reported holders of PLX - Protalix BioTherapeutics, Inc. - Common Stock (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader

MEITAV INVESTMENT HOUSE LTD

Disclosed value leader

MEITAV INVESTMENT HOUSE LTD

Comparable rows

15/15

Latest evidence

30 Jun 2022

13F Lead comparable stake: 0.3% Showing 1-6 of 15 holder rows.

Quick read

MEITAV INVESTMENT HOUSE LTD leads the comparable SEC ownership view at 0.3%.

15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens MEITAV INVESTMENT HOUSE LTD's linked filing trail.

Comparable ownership Top 5

MEITAV INVESTMENT HOUSE LTD 0.3%

BRIDGEWAY CAPITAL MANAGEMENT, LLC 0.2%

Spire Wealth Management 0.18%

RENAISSANCE TECHNOLOGIES LLC 0.14%

BlackRock Finance, Inc. 0.13%

Ownership % is shown only when SEC disclosures are safely comparable across share classes.

Detailed SEC evidence table Showing 1-6 of 15 holder rows

Holder	Evidence	Ownership %	Position	12M Net Δ	As of
MEITAV INVESTMENT HOUSE LTD	13F Company 13F	0.3%	$264,000 244,332 shares	—	30 Jun 2022
BRIDGEWAY CAPITAL MANAGEMENT, LLC	13F Company 13F	0.2%	$173,000 158,790 shares	—	30 Jun 2022
Spire Wealth Management	13F Company 13F	0.18%	$162,000 148,800 shares	—	30 Jun 2022
RENAISSANCE TECHNOLOGIES LLC	13F Company 13F	0.14%	$125,000 114,800 shares	—	30 Jun 2022
BlackRock Finance, Inc.	13F Company 13F	0.13%	$111,000 101,553 shares	—	30 Jun 2022
JANE STREET GROUP, LLC	13F Company 13F	0.1%	$91,000 83,556 shares	—	30 Jun 2022

How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q3 2022

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions

3,548,189

Rows available

Investor	Option	Weight %	Change %	SEC-reported value	* Price	Shares	Share Change	Activity	Report Period

^* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q3 2022 vs Q2 2022 Across Filers

Q2 2022 holders

Q3 2022 holders

Holder diff

-1

Investor	Q2 2022 Shares	Q3 2022 Shares	Share Diff	Share Chg %	Q2 2022 value	Q3 2022 value	Value change	Value Chg %